Septerna (SEPN) Selling, General & Administrative (2023 - 2026)
Septerna (SEPN) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Septerna | 1.49 Bn | 1.49 Bn | - | 10.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.29 Mn |
| Dec 31, 2025 | 8.28 Mn |
| Sep 30, 2025 | 7.12 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 6.86 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 2.79 Mn |